biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > 25¢ Stock

<< Previous

Bullboard Posts

Next >>

Post by JDavenporton Feb 19, 2022 10:11pm

209 Views

Post# 34445710

25¢ Stock

People like Finallytherock must be reminded that there are few proofs and certainties with a twenty five cent speculative stock. That's why the stock is priced at twenty five cents. It's a mug's game for Finallytherock to expect such answers.

But I think Finallytherock knows that, which makes his behaviour the more deplorable.

jd

<< Previous

Bullboard Posts

Next >>

Options trading in a volatile macro environment